25938EGP
- Active ingredient
- trabectedin
- Strength
- 1 mg
- Form
- powder
- Manufacturer
- cilag > soficopharm
- Route
- injection
Uses
Used for advanced soft tissue sarcoma and selected ovarian cancer indications.
Do not use if
Contraindicated in hypersensitivity to the drug or formulation components.
Side effects
Neutropenia, nausea, fatigue, liver enzyme elevation, and vomiting are common.
Warnings
Requires monitoring of blood counts and liver function.
How it works
Binds DNA and interferes with transcription and cell proliferation.
Storage
Store according to product labeling, typically refrigerated.
